PedAM
Pediatric Disease Annotations & Medicines
| Disease | arthritis |
| Phenotype | C0003864|inflammatory arthritis |
| Sentences | 3 |
| PubMedID- 25550337 | In the adjust (abatacept study to determine the effectiveness in preventing the development of rheumatoid arthritis in patients with undifferentiated inflammatory arthritis and to evaluate safety and tolerability) study, 26 patients with undifferentiated arthritis or early ra (american college of rheumatology 1987 criteria)16 received intravenous abatacept monotherapy (∼10 mg/kg) or placebo for 6 months. |
| PubMedID- 19933744 | The adjust trial (abatacept study to determine the effectiveness in preventing the development of rheumatoid arthritis in patients with undifferentiated inflammatory arthritis and to evaluate safety and tolerability) was approved by the appropriate institutional review boards/independent ethics committees, and was carried out in accordance with the ethical principles of the declaration of helsinki. |
| PubMedID- 22906083 | The prevalence rate of diabetes mellitus and osteoarthritis in inflammatory arthritis was 11.5% and 4.4%, respectively. |
Page: 1